These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3686335)

  • 1. Reutilization of 125I-UdR during growth of a solid mammary carcinoma: implications for the 125I-UdR loss technique.
    Porschen R; Porschen W; Mühlensiepen H; Feinendegen LE
    Strahlenther Onkol; 1987 Nov; 163(11):723-8. PubMed ID: 3686335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell loss from viable and necrotic tumour regions measured by 125I-UdR.
    Porschen R; Porschen W; Mühlensiepen H; Feinendegen LE
    Cell Tissue Kinet; 1983 Nov; 16(6):549-56. PubMed ID: 6627346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell loss from viable and necrotic tumor regions after local gamma irradiation measured by 125I-UdR.
    Bornschein R; Porschen R; Porschen W; Mühlensiepen H; Feinendegen LE
    Strahlenther Onkol; 1987 Feb; 163(2):114-22. PubMed ID: 3563871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of radio- and chemotoxic effects of 125I-UdR on tumour growth and host survival.
    Porschen R; Porschen W; Mühlensiepen H; Feinendegen LE
    Radiat Environ Biophys; 1985; 24(3):219-26. PubMed ID: 4034927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell loss from three established lines of the C3H mouse mammary tumor: a comparison of the 125I-UdR and the 3H-TdR-autoradiographic methods.
    Dethlefsen LA; Sorenson J; Snively J
    Cell Tissue Kinet; 1977 Sep; 10(5):447-59. PubMed ID: 922798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell population growth and cell loss in the MTG-B mouse mammary carcinoma.
    Clifton KH; Yatvin MB
    Cancer Res; 1970 Mar; 30(3):658-64. PubMed ID: 5425291
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-specific esterase activity in reactive cells in injured nervous tissue labeled with 3H-thymidine or 125iododeoxyuridine injected before injury.
    Schelper RL; Adrian EK
    J Comp Neurol; 1980 Dec; 194(4):829-44. PubMed ID: 7204643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]thymidine labels less than half of the DNA-synthesizing cells in the mouse tumour, carcinoma NT.
    Hamilton E; Dobbin J
    Cell Tissue Kinet; 1982 Jul; 15(4):405-11. PubMed ID: 7105131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of 5-(125I)iodo-2'-deoxyuridine for monitoring DNA synthesis in organ culture.
    Riches AC; Gore D; Docherty J; Littlewood V
    J Anat; 1976 Apr; 121(Pt 2):323-9. PubMed ID: 58855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic application of iodine-125 labeled iododeoxyuridine in an early ascites tumour model.
    Bloomer WD; Adelstein SJ
    Curr Top Radiat Res Q; 1978 Jan; 12(1-4):513-25. PubMed ID: 639561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoradiographic evidence for reutilization of DNA catabolites by granulocytopoiesis in the rat.
    Gerecke D; Gross R
    Scand J Haematol; 1976 Aug; 17(2):132-42. PubMed ID: 968445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The differentiation of T lymphocytes. V. Evidence for intrathymic death of most thymocytes.
    McPhee D; Pye J; Shortman K
    Thymus; 1979 Nov; 1(3):151-62. PubMed ID: 317932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The percentage labelled mitoses technique shows the mean cell cycle time to be half its true value in Carcinoma NT. II. [3H]deoxyuridine studies.
    Hamilton E; Dobbin J
    Cell Tissue Kinet; 1983 Sep; 16(5):483-92. PubMed ID: 6883432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fate of thymocytes: studies with 125I-iododeoxyuridine and 3H-thymidine in mice.
    Joel DD; Chanana AD; Cottier H; Cronkite EP; Laissue JA
    Cell Tissue Kinet; 1977 Jan; 10(1):57-69. PubMed ID: 300654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell loss and influx of labeled host cells in three transplantable mouse tumors using [125I]UdR release.
    Franko AJ; Kallman RF
    Cell Tissue Kinet; 1980 Jul; 13(4):381-93. PubMed ID: 7428012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of tumor radioactivity after the administration of either 125I- or 3H-labeled 5-iodo-2'-deoxyuridine.
    Dethlefsen LA
    Cancer Res; 1969 Sep; 29(9):1717-20. PubMed ID: 5822480
    [No Abstract]   [Full Text] [Related]  

  • 17. [DNA Turnover in the Whole Body of Tumour Bearing Mice (author's transl)].
    Kronenberger PH; Porschen W; Feinendegen LE
    Beitr Pathol; 1976 Dec; 159(4):398-412. PubMed ID: 1022223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reutilization of 131I-5-iodo-2'-deoxyuridine as compared to 3H-thymidine in mouse duodenum and mammary tumor.
    Dethlefsen LA
    J Natl Cancer Inst; 1970 Apr; 44(4):827-40. PubMed ID: 11515050
    [No Abstract]   [Full Text] [Related]  

  • 19. The validity of the labelling index in tumour studies.
    Hamilton E; Dobbin J
    Br J Cancer; 1985 Jan; 51(1):15-21. PubMed ID: 3966970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The percentage labelled mitoses technique shows the mean cell cycle time to be half its true value in Carcinoma NT. I. [3H]thymidine and vincristine studies.
    Hamilton E; Dobbin J
    Cell Tissue Kinet; 1983 Sep; 16(5):473-81. PubMed ID: 6883431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.